SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
NYSE:MMS

Maximus - MMS Stock Forecast, Price & News

$56.81
-1.69 (-2.89%)
(As of 10/7/2022 04:33 PM ET)
Add
Compare
Today's Range
$56.64
$58.09
50-Day Range
$57.43
$67.23
52-Week Range
$56.50
$88.13
Volume
346,168 shs
Average Volume
383,780 shs
Market Capitalization
$3.49 billion
P/E Ratio
19.00
Dividend Yield
1.91%
Price Target
N/A

Maximus MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
3.02% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.01mentions of Maximus in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$2.02 M Sold Last Quarter
Proj. Earnings Growth
18.75%
From $4.00 to $4.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

Business Services Sector

72nd out of 325 stocks

Business Services, Not Elsewhere Classified Industry

27th out of 100 stocks

MMS stock logo

About Maximus (NYSE:MMS) Stock

Maximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Tysons, Virginia.

Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Stock News Headlines

Estimating The Intrinsic Value Of Maximus, Inc. (NYSE:MMS)
Maximus wins $6.6B contract to continue Medicare work
See More Headlines
Receive MMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

MMS Company Calendar

Last Earnings
8/03/2022
Ex-Dividend for 8/31 Dividend
8/12/2022
Dividend Payable
8/31/2022
Today
10/07/2022
Next Earnings (Estimated)
11/17/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
35,800
Year Founded
1975

Profitability

Net Income
$291.20 million
Pretax Margin
5.18%

Debt

Sales & Book Value

Annual Sales
$4.25 billion
Cash Flow
$6.51 per share
Book Value
$24.08 per share

Miscellaneous

Free Float
60,246,000
Market Cap
$3.49 billion
Optionable
Optionable
Beta
0.70

Social Links


Key Executives

  • Mr. Bruce L. CaswellMr. Bruce L. Caswell (Age 55)
    Pres, CEO & Director
    Comp: $3.24M
  • Mr. David R. FrancisMr. David R. Francis (Age 61)
    Gen. Counsel & Sec.
    Comp: $1.04M
  • Ms. Michelle F. LinkMs. Michelle F. Link (Age 47)
    Chief HR Officer
    Comp: $915.97k
  • Mr. Thomas D. RomeoMr. Thomas D. Romeo
    Gen. Mang. of US Federal Services Segment
  • Mr. David Mutryn (Age 40)
    CFO, Principal Financial Officer & Treasurer
  • Ms. Theresa D. Golinvaux (Age 47)
    Principal Accounting Officer, Sr. VP & Corp. Controller
  • Mr. John Lambeth
    Chief Information Officer
  • Mr. Jericho Seguin
    Sr. VP of Corp. Devel.
  • Mr. David A. Casey (Age 62)
    Sr. VP of Gov. Relations & Bus. Devel.
  • Ms. Deborah Homewood
    Managing Director of Human Services - Australia













MMS Stock - Frequently Asked Questions

How have MMS shares performed in 2022?

Maximus' stock was trading at $79.67 on January 1st, 2022. Since then, MMS shares have decreased by 28.7% and is now trading at $56.82.
View the best growth stocks for 2022 here
.

Are investors shorting Maximus?

Maximus saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,810,000 shares, an increase of 12.4% from the August 31st total of 1,610,000 shares. Based on an average daily volume of 348,500 shares, the days-to-cover ratio is presently 5.2 days. Currently, 3.0% of the company's stock are sold short.
View Maximus' Short Interest
.

When is Maximus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 17th 2022.
View our MMS earnings forecast
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) posted its quarterly earnings data on Wednesday, August, 3rd. The health services provider reported $0.78 EPS for the quarter, missing the consensus estimate of $0.98 by $0.20. The health services provider had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.09 billion. Maximus had a trailing twelve-month return on equity of 16.59% and a net margin of 4.10%.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Tuesday, July 12th. Investors of record on Monday, August 15th will be paid a dividend of $0.28 per share on Wednesday, August 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date is Friday, August 12th.
Read our dividend analysis for MMS
.

Is Maximus a good dividend stock?

Maximus (NYSE:MMS) pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.90%. The dividend payout ratio is 37.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MMS will have a dividend payout ratio of 23.58% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MMS.

What guidance has Maximus issued on next quarter's earnings?

Maximus updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of $3.95-$4.15 for the period, compared to the consensus EPS estimate of $3.04. The company issued revenue guidance of $4.55 billion-$4.65 billion, compared to the consensus revenue estimate of $4.51 billion.

What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus Chief Executive Officer Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by a variety of retail and institutional investors. Top institutional investors include Exchange Traded Concepts LLC (0.02%). Insiders that own company stock include Bruce Caswell, David Francis, David Mutryn, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau, Teresa Weipert, Thomas D Romeo and Thomas D Romeo.
View institutional ownership trends
.

How do I buy shares of Maximus?

Shares of MMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $56.82.

How much money does Maximus make?

Maximus (NYSE:MMS) has a market capitalization of $3.49 billion and generates $4.25 billion in revenue each year. The health services provider earns $291.20 million in net income (profit) each year or $2.99 on an earnings per share basis.

How many employees does Maximus have?

The company employs 35,800 workers across the globe.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The official website for the company is www.maximus.com. The health services provider can be reached via phone at (703) 251-8500, via email at investorrelations@maximus.com, or via fax at 703-251-8240.

This page (NYSE:MMS) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.